Cargando…

Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation

Annexin A2 (AnxA2) was originally identified as a substrate of the pp60v-src oncoprotein in transformed chicken embryonic fibroblasts. It is an abundant protein that associates with biological membranes as well as the actin cytoskeleton, and has been implicated in intracellular vesicle fusion, the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yidong, Myrvang, Helene K, Dekker, Lodewijk V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376447/
https://www.ncbi.nlm.nih.gov/pubmed/25303710
http://dx.doi.org/10.1111/bph.12978
_version_ 1782363740165898240
author Liu, Yidong
Myrvang, Helene K
Dekker, Lodewijk V
author_facet Liu, Yidong
Myrvang, Helene K
Dekker, Lodewijk V
author_sort Liu, Yidong
collection PubMed
description Annexin A2 (AnxA2) was originally identified as a substrate of the pp60v-src oncoprotein in transformed chicken embryonic fibroblasts. It is an abundant protein that associates with biological membranes as well as the actin cytoskeleton, and has been implicated in intracellular vesicle fusion, the organization of membrane domains, lipid rafts and membrane-cytoskeleton contacts. In addition to an intracellular role, AnxA2 has been reported to participate in processes localized to the cell surface including extracellular protease regulation and cell-cell interactions. There are many reports showing that AnxA2 is differentially expressed between normal and malignant tissue and potentially involved in tumour progression. An important aspect of AnxA2 function relates to its interaction with small Ca(2+)-dependent adaptor proteins called S100 proteins, which is the topic of this review. The interaction between AnxA2 and S100A10 has been very well characterized historically; more recently, other S100 proteins have been shown to interact with AnxA2 as well. The biochemical evidence for the occurrence of these protein interactions will be discussed, as well as their function. Recent studies aiming to generate inhibitors of S100 protein interactions will be described and the potential of these inhibitors to further our understanding of AnxA2 S100 protein interactions will be discussed.
format Online
Article
Text
id pubmed-4376447
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43764472015-04-24 Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation Liu, Yidong Myrvang, Helene K Dekker, Lodewijk V Br J Pharmacol Themed Section: Annexins Vii Programme Annexin A2 (AnxA2) was originally identified as a substrate of the pp60v-src oncoprotein in transformed chicken embryonic fibroblasts. It is an abundant protein that associates with biological membranes as well as the actin cytoskeleton, and has been implicated in intracellular vesicle fusion, the organization of membrane domains, lipid rafts and membrane-cytoskeleton contacts. In addition to an intracellular role, AnxA2 has been reported to participate in processes localized to the cell surface including extracellular protease regulation and cell-cell interactions. There are many reports showing that AnxA2 is differentially expressed between normal and malignant tissue and potentially involved in tumour progression. An important aspect of AnxA2 function relates to its interaction with small Ca(2+)-dependent adaptor proteins called S100 proteins, which is the topic of this review. The interaction between AnxA2 and S100A10 has been very well characterized historically; more recently, other S100 proteins have been shown to interact with AnxA2 as well. The biochemical evidence for the occurrence of these protein interactions will be discussed, as well as their function. Recent studies aiming to generate inhibitors of S100 protein interactions will be described and the potential of these inhibitors to further our understanding of AnxA2 S100 protein interactions will be discussed. BlackWell Publishing Ltd 2015-04 2014-12-15 /pmc/articles/PMC4376447/ /pubmed/25303710 http://dx.doi.org/10.1111/bph.12978 Text en Copyright © 2015 The British Pharmacological Society http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Themed Section: Annexins Vii Programme
Liu, Yidong
Myrvang, Helene K
Dekker, Lodewijk V
Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation
title Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation
title_full Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation
title_fullStr Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation
title_full_unstemmed Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation
title_short Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation
title_sort annexin a2 complexes with s100 proteins: structure, function and pharmacological manipulation
topic Themed Section: Annexins Vii Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376447/
https://www.ncbi.nlm.nih.gov/pubmed/25303710
http://dx.doi.org/10.1111/bph.12978
work_keys_str_mv AT liuyidong annexina2complexeswiths100proteinsstructurefunctionandpharmacologicalmanipulation
AT myrvanghelenek annexina2complexeswiths100proteinsstructurefunctionandpharmacologicalmanipulation
AT dekkerlodewijkv annexina2complexeswiths100proteinsstructurefunctionandpharmacologicalmanipulation